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Antiretroviral (ARV) therapy in pregnant women is parti-
cularly important for both patients and for her future
child. Objectives: To present clinical and biological evolu-
tion of pregnant patients under ARV therapy combination
Combivir+Kaletra (CBV+KAL) with good adherence to
treatment.
The authors present the case of a patient, 22 years old,
from urban area, monitored in Infectious Diseases Clinic
Timişoara in 2010 with HIV infection stage C2. Personal
pathologic history: oropharyngeal candidiasis, toxoplasmo-
sis, suppurative otitis, bilateral coxofemoral and knee
arthritis, HIV encephalopathy depressive disorder, hypo-
trophy weight, static encephalopathy, dyslipidemia,
chronic HBV hepatitis. Biochemistry, bacteriology and
immunology were performed in the hospital laboratory
using an automatic biochemical analyzer (Konelab 301)
and an automated system VITEK 2 Compact. Assessment
of viral load by PCR was performed in the Laboratory of
the National Institute for Infectious Diseases “Prof. Dr.
Matei Balş”, Bucharest. Throughout pregnancy the patient
received ARV treatment with CBV+KAL.
Results: the beginning of pregnancy: Hb=13.1 g%,
H=4,270,000/cmm, Tr=285,000/cmm, L=6,000/cmm,
ESR=32 mm/1h, fibrinogen=3.6 mg%, ALT=42 U/L,
AST=31 U/L, cholesterol=200 mg%, triglyceride=156 mg%,
glycemia=102 mg%, ASLO=200 U/L, C-reactive protein=5
mg/L, calcemia=18 mg/dL, glossal exudate and culture on
Sabouraud medium=negative, sterile urine culture, positive
HBsAg, CD4=361 cells/µL, VL=672 copies/mL. Gynecolo-
gical examination: pregnancy 8 weeks in evolution. Coun-
seling was pregnant and gave very good compliance and
adherence to treatment. In February 2012 scheduled cesar-
ean delivery: girl of 2800 g which until now (has 2 years) is
clinically healthy, HIV negative. Father of daughter is in
our records since 2000 with HIV-infection, under ARV
therapy, combivir+nevirapine (CBV+NVP) with very good
adherence to treatment, CD4=658 cells/µL, VL=undetect-
able from 2009 to the present. There were no reported side
effects of ARV therapy administered (CBV+KAL) and
immunological tests showed a clear improvement
(CD4=420 cells/µL, VL=220 copies/mL).
Combination ARV therapy (CBV+KAL) associated with
good compliance and adherence to treatment in pregnant
women ensures optimal control of immunity.
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